Tosedostat

CAS: 238750-77-1

Ref. TM-T6301

Produktinformation

• Name: Tosedostat
• Synonyme: CHR-2797, alpha-[[(2R)-2-[(1S)-1-Hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]amino]benzeneacetic acid cyclopentyl ester
• CAS: 238750-77-1

Beschreibung

Tosedostat (CHR-2797) is an orally bioavailable inhibitor of the M1 family of aminopeptidases with potential antineoplastic activity. Tosedostat is converted intracellularly into a poorly membrane-permeable active metabolite (CHR-79888) which inhibits the M1 family of aminopeptidases, particularly puromycin-sensitive aminopeptidase (PuSA), and leukotriene A4 (LTA4) hydrolase; inhibition of these aminopeptidases in tumor cells may result in amino acid deprivation, inhibition of protein synthesis due to a decrease in the intracellular free amino acid pool, an increase in the level of the proapoptotic protein Noxa, and cell death.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 406.47
• Formel: C₂₁H₃₀N₂O₆
• Reinheit: 99.4%
• Farbe/Form: Solid
• InChl: InChI=1S/C21H30N2O6/c1-13(2)12-16(18(24)20(26)23-28)19(25)22-17(14-8-4-3-5-9-14)21(27)29-15-10-6-7-11-15/h3-5,8-9,13,15-18,24,28H,6-7,10-12H2,1-2H3,(H,22,25)(H,23,26)/t16-,17+,18?/m1/s1
• InChI Key: InChIKey=FWFGIHPGRQZWIW-DVKDBIPTSA-N
• SMILES: CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)C(O)C(=O)NO